Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Nanomedicine. 2017 Apr 19;13(6):1983–1992. doi: 10.1016/j.nano.2017.04.005

Figure 1. Selection of siRNA sequences.

Figure 1

Three siRNA sequences for each gene (MMP3, CCL12, and HIF1A) were selected and tested for the suppression of the targeted mRNAs. A549 human aveolar basal epithelial adenocarcinoma lung cells were incubated with siRNAs delivered by NLC. Gene expression was measured by the QPCR and presented as fold change relative to the untreated cells. Means ± SD are shown. *The most efficient siRNA sequences chosen for the further in vivo study.